Profiling CureVac: The pharma company reportedly offered ‘large sums of money’ by US president for coronavirus vaccine
German newspaper Die Welt recently reported that President Trump offered to buy the rights to a potential coronavirus…
Redx Pharma set to be acquired by Redmile
16 Mar 20Redx's largest shareholder Moulton Goodies has agreed to sell 74,998,896 shares representing nearly 39.5% of the company to…
How have governments across the world responded to the coronavirus outbreak?
13 Mar 20After the head of the UK treasury pledged £12bn in funding to tackle the coronavirus outbreak, we take…
DXC Technology to divest certain US businesses to Veritas for $5bn
11 Mar 20DXC will retain the rest of its healthcare practice, to service customers in the healthcare sector, including payers,…
‘Together, we will challenge the mainstream market’ says CEO after Alphagreen secures first funding round
10 Mar 20Alphagreen will use its first equity funding to expand its London-based team, develop new CBD products and branch…
Thermo Fisher Scientific to acquire Qiagen for $11.5bn
04 Mar 20Qiagen works in molecular diagnostics area, with product portfolio focused on infectious disease and other growth opportunities
UK patients set to have faster access to cannabis-based medicines following import law changes
03 Mar 20In October 2018, then-home secretary Sajid Javid passed a law making the use of medicinal cannabis to treat…
Gilead Sciences to acquire Forty Seven for $4.9bn
03 Mar 20The acquisition of Forty Seven will strengthen Gilead’s immuno-oncology research and development portfolio with the addition of Forty…
Takeda to sell certain non-core assets to Hypera Pharma for $825m
03 Mar 20The portfolio of non-core assets includes over-the-counter (OTC) and prescription pharmaceutical products and is part of Takeda’s growth…
Lilly closes $1.1bn acquisition of biopharmaceutical firm Dermira
21 Feb 20The deal expands Lilly’s portfolio of medicines with the addition of lebrikizumabfor, for atopic dermatitis and QBREXZA for…